Related references
Note: Only part of the references are listed.Overview of the 2022 WHO Classification of Thyroid Neoplasms
Zubair W. Baloch et al.
ENDOCRINE PATHOLOGY (2022)
The BRAFV600E Mutation Is Not a Risk Factor for More Aggressive Tumor Behavior in Radiogenic and Sporadic Papillary Thyroid Carcinoma at a Young Age
Liudmyla Zurnadzhy et al.
CANCERS (2021)
The primary cilium: Its role as a tumor suppressor organelle
Estanislao Peixoto et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review
Andres Coca-Pelaz et al.
ADVANCES IN THERAPY (2020)
Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer
Junguee Lee et al.
ONCOGENE (2018)
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis
Yufei Chen et al.
THYROID (2016)
Defective ciliogenesis in thyroid hurthle cell tumors is associated with increased autophagy
Junguee Lee et al.
ONCOTARGET (2016)
Comparative study of the primary cilia in thyrocytes of adult mammals
J. C. Utrilla et al.
JOURNAL OF ANATOMY (2015)
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
Greta Gandolfi et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas
Dario de Biase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer
Tae Hyuk Kim et al.
CANCER (2012)
BRAF mutation in papillary thyroid cancer:: Pathogenic role, molecular bases, and clinical implications
Mingzhao Xing
ENDOCRINE REVIEWS (2007)
Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation
JA Knauf et al.
CANCER RESEARCH (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Share Paper
